1 |
CSF3R
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer | D03235
D03235
|
Filgrastim
| [35] 2 2, 6, 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
2 |
EDNRA
| [7] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer | D01227
D01227
|
Bosentan
| [10] 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
3 |
EDNRA
| [7] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer | D07538
D07538
|
Bosentan
| [10] 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
4 |
EDNRB
| [6] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer | D01227
D01227
|
Bosentan
| [10] 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
5 |
EDNRB
| [6] Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Relaxin signaling pathway, Pathways in cancer | D07538
D07538
|
Bosentan
| [10] 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
6 |
SERPINC1
| [1] Complement and coagulation cascades Complement and coagulation cascades | D07510
D07510
|
Heparin
| [11] 47 47, 60, 70, 84, 107, 224, 226, 280, 299, 316, 317 |
7 |
SNAP25
| [2] Synaptic vesicle cycle Synaptic vesicle cycle, Insulin secretion | D00783
D00783
|
Botulinum toxin type A
| [14] 2 2, 5, 6, 7, 13, 15, 17, 36, 47, 51, 70, 113, 149, 226 |